Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

"We are honored to have such an accomplished

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
centsability4me Member Profile
Member Level 
Followed By 34
Posts 3,382
Boards Moderated 3
Alias Born 06/17/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/12/2019 12:13:37 PM
Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with Tiva Bio InvestorsHub NewsWire - 12/12/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/20/2019 12:56:29 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2019 3:35:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 4:05:22 PM
Therapeutics Solutions International Signs Agreement with Beijing Regenesis Biotechnology InvestorsHub NewsWire - 11/11/2019 9:00:00 AM
Therapeutics Solutions International Reports Augmentation of Rejuvenating Activity of Cord Blood Plasma by Pterostilbene InvestorsHub NewsWire - 11/4/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2019 12:59:28 PM
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy InvestorsHub NewsWire - 9/9/2019 9:00:00 AM
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer InvestorsHub NewsWire - 9/3/2019 9:00:00 AM
Therapeutic Solutions International, Inc. Reports Revenues Up 850% for Q2 and 850% for 1st 6 months InvestorsHub NewsWire - 8/29/2019 9:00:00 AM
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System InvestorsHub NewsWire - 8/26/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2019 4:28:47 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/13/2019 1:46:36 PM
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients InvestorsHub NewsWire - 8/5/2019 9:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/30/2019 4:44:49 PM
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer InvestorsHub NewsWire - 7/29/2019 9:00:00 AM
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Ca... InvestorsHub NewsWire - 7/22/2019 9:00:00 AM
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release InvestorsHub NewsWire - 7/15/2019 9:00:00 AM
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of InvestorsHub NewsWire - 7/11/2019 9:00:00 AM
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product InvestorsHub NewsWire - 7/8/2019 9:00:00 AM
Therapeutic Solutions International Obtains Exclusive License for Patented Clinical Stage Adult Stem Cell for Treatment of InvestorsHub NewsWire - 7/1/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 11:12:46 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 11:18:31 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/14/2019 11:22:33 AM
centsability4me Member Level  Sunday, 10/13/19 12:31:50 PM
Re: None
Post # of 13048 
"We are honored to have such an accomplished team of collaborators that included Dr. Santosh Kesari, Senior Author of the submitted paper, and Dr. Feng Lin a distinguished tumor immunologist. To have scientists of this caliber work with us at designing, executing, and now hopefully publishing the reviewed results of this important clinical trial, is the culmination of four years of work that began with the filing of our issued US Patent 9,682,047 and the submission of this manuscript on the 23rd of August
http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80602113/therapeutic-solutions-international-announces-posi?_ga=2.225445465.232006061.1569776317-435707374.1569776317

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.